GLP-1 drugs' impact beyond weight loss: effects on skin, hair, and nails
GLP-1 based medicines, widely used for obesity and type 2 diabetes, are showing dermatological consequences beyond their primary role in weight loss. Rapid weight reduction can lead to visible changes such as facial volume loss ('Ozempic face'), loose skin, hair shedding (telogen effluvium), and nail changes, often reflecting nutritional stress. The article emphasizes the need for coordinated care between endocrinologists and dermatologists to manage these effects, which can impact comfort and confidence. Furthermore, GLP-1s show early anti-inflammatory promise for skin diseases like psoriasis and hidradenitis suppurativa, especially when coexisting with metabolic dysfunction, though more studies are needed.
Key Points
- GLP-1 based medicines, used for obesity and type 2 diabetes, have visible dermatological consequences.
- Rapid weight loss can lead to facial volume loss, loose skin, hair shedding, and nail changes.
- These changes may indicate nutritional deficiencies or underlying conditions, requiring proper assessment.
- Coordinated care between endocrinologists and dermatologists is crucial for managing these effects and planning aesthetic procedures.
- GLP-1s show early anti-inflammatory promise for conditions like psoriasis and hidradenitis suppurativa, especially with metabolic dysfunction.
Exam Facts
- Medicines: GLP-1 (Glucagon-Like Peptide-1) based medicines.
- Conditions treated: Obesity, Type 2 Diabetes.
- Common side effects: 'Ozempic face', telogen effluvium (hair shedding).
- Skin conditions with potential benefits: Psoriasis, hidradenitis suppurativa.
- Author: Dr. Monisha Madhumita, consultant dermatologist.
Read it. Retain it. Recall it.
Get spaced-repetition flashcards, daily quizzes and offline access — free on Android.